Rezultaty - Pradeep Varma
- Rezultaty 1 - 2 Rezultaty od 2
-
1
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease od Haakon B. Nygaard, Allison F. Wagner, Garrett S Bowen, Susan P. Good, Martha G. MacAvoy, Kurt A Strittmatter, A Kaufman, Brian J. Rosenberg, Tomoko Sekine-Konno, Pradeep Varma, Kewei Chen, Anthony J. Koleske, Eric M. Reiman, Stephen M. Strittmatter, Christopher H. van Dyck
Wydane 2015Artigo -
2
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET od Adam P. Mecca, Ming‐Kai Chen, Ryan S. O’Dell, Mika Naganawa, Takuya Toyonaga, Tyler A. Godek, Joanna E. Harris, Hugh H. Bartlett, Wenzhen Zhao, Nabeel Nabulsi, Brent C. Vander Wyk, Pradeep Varma, Amy F.T. Arnsten, Yiyun Huang, Richard E. Carson, Christopher H. van Dyck
Wydane 2020Artigo
Narzędzie wyszukiwania:
Podobne hasła
Alzheimer's disease
Disease
Medicine
Adverse effect
Biochemistry
Biology
Biomarker
Cognitive impairment
Dementia
FYN
Internal medicine
Membrane
Neuroscience
Pathology
Pet imaging
Pharmacology
Positron emission tomography
Proto-oncogene tyrosine-protein kinase Src
Psychology
Receptor
Synaptic vesicle
Tolerability
Vesicle